T CELLS MODIFIED TO OVEREXPRESS PHF19

Technology
E-107-2017
Patent ID
E-107-2017-0-US-01
Country
US
Application Type
 
Patent Status
Abandoned
Patent Number
 
Publication Number
 
Application Number
62/515,105
IC
NCI
Date Filed
Date Issued
 
Patent PDF
 
Related Technologies
TAB-4030     Overexpression of Phf19 on T Cells Enhances Therapeutic Effects of T Cell-Based Therapies (such as Chimeric Antigen Receptor [CAR] Therapies)